Aprea Therapeutics, Inc. (APRE)
SG&A Expenses
$6.50M
TTM · Period ending: · USD
APRE SG&A Expenses
Latest reported$6.50Mperiod ending
Latest reported$6.50Mperiod ending
APRE SG&A Expenses ($2.46M → $6.50M)
Annual SG&A Expenses
High-resolution chart · PNG
APRE sg&a expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 6,476,560 | |
| 6,458,699 | |
| 8,420,651 | |
| 20,969,771 | |
| 13,550,478 | |
| 14,931,887 | |
| 8,423,372 | |
| 2,294,671 | |
| 2,459,744 |